This week’s BioBlog looks at several interesting developments in the use of technology in the healthcare field. Three companies are looking to use a blockchain-based application to secure and encrypt provider data. Researchers have found over 850 genetic alterations may be the reason why cancer
This week's Innovation Partners BioBlog looks at some of the business aspects of the healthcare industry. Walmart reportedly took baby steps towards the acquisition of insurer Humana last month, while Aetna has agreed to pass drug discounts on to patients, a move hailed by many as a positive step.
This week’s Innovation Partners BioBlog takes a look at the legislation moving through the government now to fund research, treatment and more. Senator Warren is proposing additional subsidies for healthcare insurance, while the new budget bill increases funding for research, drug treatment and
This week’s BioBlog focuses on cancer - new drugs, advances in diagnosis and disease tracking, and improvement in healthcare and treatment access for patients. Medicare has agreed to pay for important testing to match drugs to patients with advanced cancer, and Blue Cross is launching new projects
Innovation is all around us, and this week’s BioBlog from Innovation Partners examines innovation in all its forms. Two women entrepreneurs are working to develop an at-home cervical cancer screening test that will make it easier for women to test for the deadly disease, while an at-home test for
Change is coming - whether you like it or not. That’s the gist of HHS Secretary Alex Azar’s statement to a group of hospital executives. Azar is pushing for changes to pricing transparency and other factors affecting the cost of healthcare. Meanwhile, United Healthcare, responding to consumer
This week, Innovation Partners’ BioBlog takes a look at the hidden profits in the prescription drug supply chain and Roche’s acquisition of Flatiron, a data firm backed by Google that has made serious inroads into oncology care. An alliance formed by several groups will effectively cover 7 million
This week’s Innovation Partners BioBlog features updates on the White House’s new budget and proposed changes to reimbursement. Anthem backtracks on a controversial decision aimed at reducing emergency room visit. New drugs reach the market, including drugs to treat prostate cancer and